Literature DB >> 32232573

Multimodal analysis using [11C]PiB-PET/MRI for functional evaluation of patients with Alzheimer's disease.

Hidehiko Okazawa1, Masamichi Ikawa2,3, Minyoung Jung2,4, Rikiya Maruyama2, Tetsuya Tsujikawa2, Tetsuya Mori2, Mahmudur G M Rahman2,5, Akira Makino2, Yasushi Kiyono2, Hirotaka Kosaka4.   

Abstract

BACKGROUND: Multimodal PET/MRI image data simultaneously obtained from patients with early-stage of Alzheimer's disease (eAD) were assessed in order to observe pathophysiologic and functional changes, as well as alterations of morphology and connectivity in the brain. Fifty-eight patients with mild cognitive impairment and early dementia (29 males, 69 ± 12 years) underwent [11C]Pittsburgh compound-B (PiB) PET/MRI with 70-min PET and MRI scans. Sixteen age-matched healthy controls (CTL) (9 males, 68 ± 11 years) were also studied with the same scanning protocol. Cerebral blood flow (CBF) was calculated from the early phase PET images using the image-derived input function method. A standardized uptake value ratio (SUVr) was calculated from 50 to 70 min PET data with a reference region of the cerebellar cortex. MR images such as 3D-T1WI, resting-state functional MRI (RS-fMRI), diffusion tensor image (DTI), and perfusion MRI acquired during the dynamic PET scan were also analyzed to evaluate various brain functions on MRI.
RESULTS: Twenty-seven of the 58 patients were determined as eAD based on the results of PiB-PET and clinical findings, and a total of 43 subjects' data including CTL were analyzed in this study. PiB SUVr values in all cortical regions of eAD were significantly greater than those of CTL. The PiB accumulation intensity was negatively correlated with cognitive scores. The regional PET-CBF values of eAD were significantly lower in the bilateral parietal lobes and right temporal lobe compared with CTL, but not in MRI perfusion; however, SPM showed regional differences on both PET- and MRI-CBF. SPM analysis of RS-fMRI delineated regional differences between the groups in the anterior cingulate cortex and the left precuneus. VBM analysis showed atrophic changes in the AD group in a part of the bilateral hippocampus; however, analysis of fractional anisotropy calculated from DTI data did not show differences between the two groups.
CONCLUSION: Multimodal analysis conducted with various image data from PiB-PET/MRI scans showed differences in regional CBF, cortical volume, and neuronal networks in different regions, indicating that pathophysiologic and functional changes in the AD brain can be observed from various aspects of neurophysiologic parameters. Application of multimodal brain images using PET/MRI would be ideal for investigating pathophysiologic changes in patients with dementia and other neurodegenerative diseases.

Entities:  

Keywords:  Amyloid imaging; Cerebral blood flow; Functional MRI; Multimodal analysis; PET/MRI; Quantitative analysis

Year:  2020        PMID: 32232573     DOI: 10.1186/s13550-020-00619-z

Source DB:  PubMed          Journal:  EJNMMI Res            Impact factor:   3.138


  4 in total

1.  Cerebral Oxidative Stress in Early Alzheimer's Disease Evaluated by 64Cu-ATSM PET/MRI: A Preliminary Study.

Authors:  Hidehiko Okazawa; Masamichi Ikawa; Tetsuya Tsujikawa; Tetsuya Mori; Akira Makino; Yasushi Kiyono; Yasunari Nakamoto; Hirotaka Kosaka; Makoto Yoneda
Journal:  Antioxidants (Basel)       Date:  2022-05-22

2.  Noninvasive Measurement of [11C]PiB Distribution Volume Using Integrated PET/MRI.

Authors:  Hidehiko Okazawa; Masamichi Ikawa; Tetsuya Tsujikawa; Akira Makino; Tetsuya Mori; Yasushi Kiyono; Hirotaka Kosaka
Journal:  Diagnostics (Basel)       Date:  2020-11-24

Review 3.  PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction.

Authors:  Masamichi Ikawa; Hidehiko Okazawa; Yasunari Nakamoto; Makoto Yoneda
Journal:  Antioxidants (Basel)       Date:  2020-09-14

4.  Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.

Authors:  Hong-Mei Zeng; Hua-Bo Han; Qi-Fang Zhang; Hua Bai
Journal:  Neural Regen Res       Date:  2021-01       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.